陆红：上海仁济医院消化科主任医师

　　陆红，博士主任医师，博士研究生导师消化道疾病（包括幽门螺杆菌相关的胃炎和癌前病变）的诊治1.Lu H, Zhang W, Graham DY. Bismuth-containing quadruple therapy for Helicobacter pylori: lessons from China. Eur J Gastroenterol Hepatol. 2013 Oct;25(10):1134-40.2.Liao J, Zheng Q, Liang X, Zhang W, Sun Q, Liu W, Xiao S, Graham DY, Lu H. Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy. Helicobacter. 2013 Oct;18(5):373-7.3.Liang X, Xu X, Zheng Q, Zhang W, Sun Q, Liu W, Xiao S, Lu H*. Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study. Clin Gastroenterol Hepatol. 2013 Jul;11(7):802-74.Lu H, Wang Z, Zheng Q, Li JH, Chong XQ, Xiao SD. Efficient differentiation of newly derived human embryonic stem cells from discarded blastocysts into hepatocyte-like cells. J Dig Dis. 2010 Dec;11(6):376-82. 5.Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H*. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer.2010 Jan 1;116(1):41-9. 6.Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, Xiao S, Lu H*. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest. 2008 Dec;88(12):1358-66. 7.Sun QJ, Liang X, Zheng Q, Gu WQ, Liu WZ, Xiao SD, Lu H.. Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai. World J Gastroenterol. 2010 Oct 28;16(40):5118-21.8.Sun Q, Liang X, Zheng Q, Liu W, Xiao S, Gu W, Lu H*. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication. Helicobacter. 2010 Jun;15(3):233-8. 9.Zhang Z, Zheng Q, Chen X, Xiao S, Liu W, Lu H. The Helicobacter pylori duodenal ulcer promoting gene, dupA in China. BMC Gastroenterol. 2008 Oct 25;8:49.10.Lu H, Wu JY, Beswick EJ, Ohno T, Odenbreit S, Haas R, Reyes VE, Kita M, Graham DY, Yamaoka Y. Functional and Intracellular Signaling Differences Associated with the Helicobacter pylori AlpAB Adhesin from Western and East Asian Strains. J Biol Chem. 2007 Mar 2;282(9):6242-54. 11.Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol. 2005 Nov;21(6):653-9. 12.Lu H, Wu JY, Kudo T, Ohno T, Graham DY, Yamaoka Y. Regulation of Interleukin-6 Promoter Activation in Gastric Epithelial CellsInfected with Helicobacter pylori. Mol Biol Cell. 2005 Oct;16(10):4954-66. 13.Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology. 2005 Apr;128(4):833-48. 14.Lu H, Graham DY, Yamaoka Y. The Helicobacter pylori restriction endonuclease-replacing gene, hrgA, andclinical outcome: comparison of East Asia and Western countries. Dig Dis Sci. 2004 Sep;49(9):1551-5. 15.Lu H, Zhang DZ, Hu PJ, Li ZS, Lu XH, Fang XC, Xiao SD. One-week regimens containing ranitidine bismuth citrate, furazolidone andeither amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study. Aliment Pharmacol Ther. 2001 Dec;15(12):1975-9. 2009上海医学科技奖（三等奖）（第一完成人）2007年上海市卫生系统第十一届银蛇奖(二等奖)1992年7月毕业于上海第二医科大学医学系（获学士学位），2003年6月获博士学位。2002年4月至2005年7月在美国贝勒医学院（Baylor college of Medicine）从事博士后研究。